Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk

Award Number: R33DA062217
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2026
PERIOD OF PERFORMANCE END DATE: 08/30/2030

Group Awards By:

View Award Description

A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk - PROJECT SUMMARY/ABSTRACT Between 2015 and 2019, overdose deaths translated to 1.25 million years of life lost among adolescents and young adults (“youth”), and the percent change in fatal overdose death rates among adolescents was higher than adults between 2019 and 2020. Similar to adults, illicitly manufactured fentanyl (IMF) is the major driver of drug overdose deaths in youth. Unlike adults, youth are more commonly exposed to IMF through counterfeit pills, and some youth are unaware that they are using a pill that is counterfeit and thus unintentionally exposed to IMF. Unfortunately, any youth who uses a counterfeit pill or other drug is at risk for an overdose, even after first use. There is an urgent need for evidence-based overdose prevention interventions for youth. Within the healthcare setting, youth primary care providers routinely provide injury prevention anticipatory guidance as part of annual comprehensive physical exams and are well positioned to provide anticipatory guidance for overdose prevention. Through this R61/R33 mechanism we propose to develop and evaluate the efficacy of an universal overdose prevention intervention that will increase: (1) awareness of the risks of fentanyl and other emerging drugs in the drug supply, (2) knowledge of strategies to reduce overdose risk, and (3) recognition and response to overdose. In the R61, in collaboration with our existing Youth Community Advisory Board, we proposed to use the Informational-Motivational-Behavioral Skills Model to develop an overdose prevention intervention to be delivered in primary care setting. We will pilot the intervention in two primary care settings at Boston Medical Center, Pediatric Primary Care and Family Medicine, to assess acceptability and feasibility for providers and youth ages 13 to 26 years who are being seen for an annual comprehensive physical exam. We will do this through a pilot two-arm cluster randomized controlled trial (RCT) that is randomized at the provider level. During the pilot trial, we will share preliminary data with the Community Advisory Board to inform any needed adaptations to the intervention. If the intervention is acceptable and feasible to providers we will transition to evaluating the intervention’s efficacy in a larger RCT during the R33. In the R33, we will again conduct a two-arm cluster RCT randomized at the provider level using the same inclusion/exclusion criteria, procedures, and study measures as the R61. Youth outcomes will be evaluated at one-year follow up and the primary outcome will be youth knowledge of the risk associated with fentanyl and other emerging drugs in the drug supply. Secondary outcomes will include youth knowledge of strategies to reduce overdose risk, recognize and respond to an overdose. If the universal youth overdose prevention intervention is effective this will benefit youth and public health generally as youth will be better prepared to decrease their risk for overdose, and recognize and respond to others who have an overdose.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $1,106,433 )
2026	2026	BOSTON MEDICAL CENTER CORPORATION	1 BOSTON MEDICAL CTR PL	BOSTON	MA	02118	SUFFOLK	USA	Drug Use and Addiction Research Programs	000	2	7/30/2026	EXTENSION WITH OR WITHOUT FUNDS	$1,106,433
														Subtotal = $1,106,433

Grand Total All Awards = $1,106,433

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk

Award Number: R33DA062217

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2026

PERIOD OF PERFORMANCE END DATE: 08/30/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer